Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding

Noncharged detergents are used as excipients in drug formulations. Until recently, they were considered as inert compounds, enhancing drug absorption essentially by improving drug solubility. However, many detergents insert into lipid membranes, although to different extents, and change the lateral packing density of membranes at high concentrations. Moreover, they bind to the efflux transporter P-glycoprotein (P-gp) and most likely to related transporters and metabolising enzymes with overlapping substrate specificities. If their affinity to P-gp is higher than that of the coadministered drug they act as modulators or inhibitors of P-gp and enhance drug absorption. Inhibition of P-gp and related proteins can, however, cause severe side effects. This paper first reviews the membrane binding propensity of different noncharged detergents (including poloxamers) and discusses their ability to bind to P-gp. Second, literature data on drug uptake enhancement by noncharged detergents, obtained in vivo and in vitro, are analysed at the molecular level. The present analysis provides the tools for an approximate and simple prior estimate of the membrane and P-gp binding ability of noncharged detergents based on a modular binding approach.

[1]  Raphael C. Lee,et al.  Direct observation of poloxamer 188 insertion into lipid monolayers. , 2002, Biophysical journal.

[2]  Kim L R Brouwer,et al.  Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  W. Graninger,et al.  Tolerability of a new vitamin K1 preparation for parenteral administration to adults: one case of anaphylactoid reaction. , 1987, Clinical therapeutics.

[4]  V. Mahler,et al.  Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  A. E. Senior,et al.  Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. , 1994, Biochemistry.

[6]  Anna Seelig,et al.  Quantification and characterization of P-glycoprotein-substrate interactions. , 2006, Biochemistry.

[7]  Gary Martin,et al.  Surfactant Systems: Their Chemistry, Pharmacy and Biology , 1984 .

[8]  F. Boess,et al.  In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes. , 2004, International journal of pharmaceutics.

[9]  S. Wassall,et al.  Deuterium NMR study of the interaction of alpha-tocopherol with a phospholipid model membrane. , 1986, Biochemistry.

[10]  Alexander V Kabanov,et al.  Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. , 2003, Advanced drug delivery reviews.

[11]  B. Roelofsen,et al.  Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. , 1975, Biochimica et biophysica acta.

[12]  S. McLaughlin,et al.  Effect of monolayer surface pressure on the activities of phosphoinositide-specific phospholipase C-beta 1, -gamma 1, and -delta 1. , 1994, Biochemistry.

[13]  J. L. Biedler,et al.  Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. , 1972, Cancer research.

[14]  J. Seelig,et al.  Lipid conformation in model membranes and biological membranes , 1980, Quarterly Reviews of Biophysics.

[15]  A. Garnier-Suillerot,et al.  The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells. , 1995, Biochemical pharmacology.

[16]  Ronald T Borchardt,et al.  A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. , 2002, Journal of pharmaceutical sciences.

[17]  H. Heerklotz Triton promotes domain formation in lipid raft mixtures. , 2002, Biophysical journal.

[18]  J. Seelig,et al.  Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity. , 2006, Biophysical journal.

[19]  C. O’Driscoll,et al.  The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. , 2003, Pharmaceutical research.

[20]  G. van Meer,et al.  Lipid Traffic: The ABC of Transbilayer Movement , 2000, Traffic.

[21]  Y Zhang,et al.  The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.

[22]  H. Omote,et al.  Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism. , 2006, Biophysical journal.

[23]  D. L. Le Couteur,et al.  Hyperlipidemia and surfactants: the liver sieve is a link. , 2006, Atherosclerosis.

[24]  L M Mir,et al.  Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities. , 1998, Cancer biochemistry biophysics.

[25]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[26]  K. Hirsch‐Ernst,et al.  Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. , 2001, Toxicology.

[27]  R. Borchardt,et al.  Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.

[28]  C. Gau,et al.  Interactions of Pluronics with phospholipid monolayers at the air-water interface. , 2005, Journal of colloid and interface science.

[29]  A. Seelig,et al.  Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.

[30]  A. Seelig,et al.  Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. , 1987, Biochimica et biophysica acta.

[31]  A. Blume,et al.  A comparative study of the phase transitions of phospholipid bilayers and monolayers. , 1979, Biochimica et biophysica acta.

[32]  Gérard Hopfgartner,et al.  P‐Glycoprotein and Surfactants: Effect on Intestinal Talinolol Absorption , 2005, Clinical pharmacology and therapeutics.

[33]  V. Ling,et al.  Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. , 1998, European journal of biochemistry.

[34]  A. Seelig,et al.  Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  J. Huwyler,et al.  Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension. , 2002, International journal of pharmaceutics.

[36]  J. Silverman,et al.  Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) , 1999, Pharmaceutical Research.

[37]  A. Seelig,et al.  Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. , 2000, International journal of clinical pharmacology and therapeutics.

[38]  Marie-Hélène Dufresne,et al.  Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[39]  F. Sharom,et al.  Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. , 2001, Biochemistry.

[40]  T. Druley,et al.  From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance , 2001, Cellular and Molecular Life Sciences CMLS.

[41]  A. Seelig,et al.  The rate of P-glycoprotein activation depends on the metabolic state of the cell. , 2004, Biochemistry.

[42]  P. Pohl,et al.  Ionophoric activity of pluronic block copolymers. , 2004, Biochemistry.

[43]  J. Huwyler,et al.  Impact of solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats , 2003, Biopharmaceutics & drug disposition.

[44]  Jochem Alsenz,et al.  The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. , 2003, Journal of pharmaceutical sciences.

[45]  C. Higgins,et al.  Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. , 2005, Molecular immunology.

[46]  A. Seelig A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[47]  V. Ling,et al.  Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. , 1993, Cancer research.

[48]  N. Melik-Nubarov,et al.  Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers. , 2005, Biochemistry.

[49]  Christopher J. H. Porter,et al.  An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine , 2002, AAPS PharmSci.

[50]  R L Hunter,et al.  Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. , 2000, Life sciences.

[51]  Z. Sauna,et al.  Characterization of the Catalytic Cycle of ATP Hydrolysis by Human P-glycoprotein , 2001, The Journal of Biological Chemistry.

[52]  Caitriona M. O'Driscoll,et al.  The Effects of Pluronic® Block Copolymers and Cremophor® EL on Intestinal Lipoprotein Processing and the Potential Link with P-Glycoprotein in Caco-2 Cells , 2003, Pharmaceutical Research.

[53]  M. Sayegh,et al.  P-glycoprotein--a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity? , 2003, Current drug targets.

[54]  James E Polli,et al.  Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[55]  K. Anderson,et al.  Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. , 1995, Archives of biochemistry and biophysics.

[56]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Beyer,et al.  Softening of Membrane Bilayers by Detergents Elucidated by Deuterium NMR Spectroscopy , 2000 .

[58]  Donald W. Miller,et al.  Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[59]  Mark L. Greenberg,et al.  Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  A. Seelig Unraveling membrane-mediated substrate-transporter interactions. , 2006, Biophysical journal.

[61]  K. Kjaer,et al.  Interaction between lipid monolayers and poloxamer 188: an X-ray reflectivity and diffraction study. , 2005, Biophysical journal.

[62]  R L Hunter,et al.  Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer. , 1999, Life sciences.

[63]  R S Weinstein,et al.  Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. , 1991, Cancer research.

[64]  D. Putnam,et al.  Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process. , 2004, Journal of pharmaceutical sciences.

[65]  Guangzhao Mao,et al.  Effect of chain lengths of PEO-PPO-PEO on small unilamellar liposome morphology and stability: an AFM investigation. , 2005, Journal of colloid and interface science.

[66]  G Ecker,et al.  The importance of a nitrogen atom in modulators of multidrug resistance. , 1999, Molecular pharmacology.

[67]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[68]  T. Litman,et al.  Pumping of Drugs by P-Glycoprotein: A Two-Step Process? , 2003, Journal of Pharmacology and Experimental Therapeutics.

[69]  W. Sawyer,et al.  Reversal of multidrug resistance by surfactants. , 1992, British journal of cancer.

[70]  A. Seelig,et al.  Real-time monitoring of P-glycoprotein activation in living cells. , 2002, Biochemistry.

[71]  J Verweij,et al.  Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.

[72]  Y. Tanigawara Role of P-glycoprotein in drug disposition. , 2000, Therapeutic drug monitoring.

[73]  J. Seelig,et al.  Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration. , 2000, Biophysical journal.

[74]  Terry R Stouch,et al.  Progress in understanding the structure-activity relationships of P-glycoprotein. , 2002, Advanced drug delivery reviews.

[75]  A. P. Tulloch,et al.  A deuterium NMR study of labelled n-alkanol anesthetics in a model membrane. , 1986, Chemistry and physics of lipids.

[76]  M. Wenk,et al.  Octyl-beta-D-glucopyranoside partitioning into lipid bilayers: thermodynamics of binding and structural changes of the bilayer. , 1997, Biophysical journal.

[77]  K. Kjaer,et al.  Lipid corralling and poloxamer squeeze-out in membranes. , 2004, Physical review letters.

[78]  Y. Lo,et al.  Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[79]  M. Sehested,et al.  The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. , 1990, Cancer communications.

[80]  J. Lankelma,et al.  P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport. , 1991, Biochemical pharmacology.

[81]  Alexander V. Kabanov,et al.  Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers , 1999, Pharmaceutical Research.

[82]  Alexander V. Kabanov,et al.  Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers , 1999, Pharmaceutical Research.

[83]  Y. Assaraf,et al.  Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. , 1995, European journal of biochemistry.

[84]  H. Omote,et al.  Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein* , 2003, Journal of Biological Chemistry.

[85]  D Mackay,et al.  A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. , 1988, Journal of Pharmacy and Science.

[86]  A. E. Senior,et al.  Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form. , 1998, Biochimica et biophysica acta.

[87]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Grégori Gerebtzoff,et al.  Halogenation of Drugs Enhances Membrane Binding and Permeation , 2004, Chembiochem : a European journal of chemical biology.

[89]  A. Seelig,et al.  Inhibitors of multidrug efflux transporters: their membrane and protein interactions. , 2005, Mini reviews in medicinal chemistry.

[90]  T. Litman,et al.  Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. , 1997, Biochimica et biophysica acta.

[91]  F. Sharom,et al.  Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. , 1974, British Journal of Cancer.

[92]  Jörg Huwyler,et al.  In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. , 2004, Biopharmaceutics & drug disposition.

[93]  Alberto Guenzi,et al.  Improvement of the Bioavailability of Colchicine in Rats by Co-administration of D-α-Tocopherol Polyethylene Glycol 1000 Succinate and a Polyethoxylated Derivative of 12-Hydroxy-Stearic Acid , 2002, Arzneimittelforschung.

[94]  Y. Assaraf,et al.  Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. , 1999, European journal of biochemistry.